|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosenthal AN and Jacobs IJ: The role of CA
125 in screening for ovarian cancer. Int J Biol Markers.
13:216–220. 1998.PubMed/NCBI
|
|
3
|
Maggino T and Gadducci A: Serum markers as
prognostic factors in epithelial ovarian cancer: An overview. Eur J
Gynaecol Oncol. 21:64–69. 2000.PubMed/NCBI
|
|
4
|
Bast RC Jr, Xu FJ, Yu YH, Barnhill S,
Zhang Z and Mills GB: CA 125: The past and the future. Int J Biol
Markers. 13:179–187. 1998.PubMed/NCBI
|
|
5
|
Bast RC Jr, Klug TL, St John E, Jenison E,
Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker
L, et al: A radioimmunoassay using a monoclonal antibody to monitor
the course of epithelial ovarian cancer. N Engl J Med. 309:883–887.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lundwall A, Band V, Blaber M, Clements JA,
Courty Y, Diamandis EP, Fritz H, Lilja H, Malm J, Maltais LJ, et
al: A comprehensive nomenclature for serine proteases with homology
to tissue kallikreins. Biol Chem. 387:637–641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yousef GM and Diamandis EP: The new human
tissue kallikrein gene family: Structure, function, and association
to disease. Endocr Rev. 22:184–204. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Diamandis EP, Yousef GM, Soosaipillai AR
and Bunting P: Human kallikrein 6 (zyme/protease M/neurosin): A new
serum biomarker of ovarian carcinoma. Clin Biochem. 33:579–583.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Diamandis EP, Yousef GM, Soosaipillai AR,
Grass L, Porter A, Little S and Sotiropoulou G: Immunofluorometric
assay of human kallikrein 6 (zyme/protease M/neurosin) and
preliminary clinical applications. Clin Biochem. 33:369–375. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Diamandis EP, Scorilas A, Fracchioli S,
Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L,
Yousef GM, Stenman UH, et al: Human kallikrein 6 (hK6): A new
potential serum biomarker for diagnosis and prognosis of ovarian
carcinoma. J Clin Oncol. 21:1035–1043. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo LY, Bunting P, Scorilas A and
Diamandis EP: Human kallikrein 10: a novel tumor marker for ovarian
carcinoma? Clinica Chim Acta. 306:11–118. 2001. View Article : Google Scholar
|
|
12
|
Chen X, Li WL, Zhang YL, Wu Q, Guo YM and
Bai ZL: Meta-analysis of quantitative diffusion-weighted MR imaging
in the differential diagnosis of breast lesions. BMC Cancer.
10:6932010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Whiting PF, Rutjes AW, Westwood ME,
Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA and Bossuyt
PM: QUADAS-2 Group: QUADAS-2: A revised tool for the quality
assessment of diagnostic accuracy studies. Ann Intern Med.
155:529–536. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zamora J, Abraira V, Muriel A, Khan K and
Coomarasamy A: Meta-DiSc: A software for meta-analysis of test
accuracy data. BMC Med Res Methodol. 6:312006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bandiera E, Zanotti L, Fabricio AS, Bucca
E, Squarcina E, Romani C, Tassi R, Bignotti E, Todeschini P, Tognon
G, et al: Cancer antigen 125, human epididymis 4, kallikrein 6,
osteopontin and soluble mesothelin-related peptide immunocomplexed
with immunoglobulin M in epithelial ovarian cancer diagnosis. Clin
Chem Lab Med. 51:1815–1824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koh SC, Huak CY, Lutan D, Marpuang J,
Ketut S, Budiana NG, Saleh AZ, Aziz MF, Winarto H, Pradjatmo H, et
al: Combined panel of serum human tissue kallikreins and CA-125 for
the detection of epithelial ovarian cancer. J Gynecol Oncol.
23:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
El Sherbini MA, Sallam MM, Shaban EA and
El-Shalakany AH: Diagnostic value of serum kallikrein-related
peptidases 6 and 10 versus CA125 in ovarian cancer. IInt J Gynecol
Cancer. 21:625–632. 2011. View Article : Google Scholar
|
|
18
|
Campos SM and Ghosh S: A current review of
targeted therapeutics for ovarian cancer. J Oncol. 2010:1493622010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mills GB, Bast RC Jr and Srivastava S:
Future for ovarian cancer screening: Novel markers from emerging
technologies of transcriptional profiling and proteomics. J Natl
Cancer Inst. 93:1437–1439. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whiting P, Rutjes AW, Reitsma JB, Glas AS,
Bossuyt PM and Kleijnen J: Sources of variation and bias in studies
of diagnostic accuracy: A systematic review. Ann Intern Med.
140:189–202. 2004. View Article : Google Scholar : PubMed/NCBI
|
